Envalior

Photo

Lanxess-Advent Plastics JV Launched as Envalior

Under the name Envalior, German specialty chemicals producer Lanxess and private equity investor Advent International launched their new 40:60 joint venture for high performance engineering plastics at the beginning of the second quarter, after the deal cleared all regulatory hurdles earlier.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.